Editorial: The Effect of Bias on Estimation of Improved Survival after Diagnosis of Barrett's Esophagus

Liam Zakko, Kavel Visrodia, Kenneth Ke Ning Wang, Prasad G Iyer

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Adjustments for lead and length time bias has been used when examining apparent survival advantages from screening procedures. However, these estimates depend on several assumptions and are modeled from malignancies that are fairly common and large cohorts are available. In smaller retrospective cohorts, adjustments themselves may be based on estimates that may not be biological nor statistically accurate, which can lead to divergent results as has been found in several recent studies of screening in Barrett's esophagus. Only a prospective randomized controlled trial can really determine the benefit though this may not feasible.

Original languageEnglish (US)
Pages (from-to)1265-1266
Number of pages2
JournalAmerican Journal of Gastroenterology
Volume112
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Barrett Esophagus
Randomized Controlled Trials
Neoplasms
Lead

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Editorial : The Effect of Bias on Estimation of Improved Survival after Diagnosis of Barrett's Esophagus. / Zakko, Liam; Visrodia, Kavel; Wang, Kenneth Ke Ning; Iyer, Prasad G.

In: American Journal of Gastroenterology, Vol. 112, No. 8, 01.08.2017, p. 1265-1266.

Research output: Contribution to journalReview article

@article{c97601384c0f4c018ed440b9d22367f4,
title = "Editorial: The Effect of Bias on Estimation of Improved Survival after Diagnosis of Barrett's Esophagus",
abstract = "Adjustments for lead and length time bias has been used when examining apparent survival advantages from screening procedures. However, these estimates depend on several assumptions and are modeled from malignancies that are fairly common and large cohorts are available. In smaller retrospective cohorts, adjustments themselves may be based on estimates that may not be biological nor statistically accurate, which can lead to divergent results as has been found in several recent studies of screening in Barrett's esophagus. Only a prospective randomized controlled trial can really determine the benefit though this may not feasible.",
author = "Liam Zakko and Kavel Visrodia and Wang, {Kenneth Ke Ning} and Iyer, {Prasad G}",
year = "2017",
month = "8",
day = "1",
doi = "10.1038/ajg.2017.185",
language = "English (US)",
volume = "112",
pages = "1265--1266",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Editorial

T2 - The Effect of Bias on Estimation of Improved Survival after Diagnosis of Barrett's Esophagus

AU - Zakko, Liam

AU - Visrodia, Kavel

AU - Wang, Kenneth Ke Ning

AU - Iyer, Prasad G

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Adjustments for lead and length time bias has been used when examining apparent survival advantages from screening procedures. However, these estimates depend on several assumptions and are modeled from malignancies that are fairly common and large cohorts are available. In smaller retrospective cohorts, adjustments themselves may be based on estimates that may not be biological nor statistically accurate, which can lead to divergent results as has been found in several recent studies of screening in Barrett's esophagus. Only a prospective randomized controlled trial can really determine the benefit though this may not feasible.

AB - Adjustments for lead and length time bias has been used when examining apparent survival advantages from screening procedures. However, these estimates depend on several assumptions and are modeled from malignancies that are fairly common and large cohorts are available. In smaller retrospective cohorts, adjustments themselves may be based on estimates that may not be biological nor statistically accurate, which can lead to divergent results as has been found in several recent studies of screening in Barrett's esophagus. Only a prospective randomized controlled trial can really determine the benefit though this may not feasible.

UR - http://www.scopus.com/inward/record.url?scp=85026858694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026858694&partnerID=8YFLogxK

U2 - 10.1038/ajg.2017.185

DO - 10.1038/ajg.2017.185

M3 - Review article

C2 - 28766563

AN - SCOPUS:85026858694

VL - 112

SP - 1265

EP - 1266

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 8

ER -